Atlas Trials

Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients

Clinical trial NCT02755844 · COMPLETED

Trial details

NCT number
NCT02755844
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Endometrial Cancer
Start date
2016-09-23
Primary completion
2018-11-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.